This is a prospective and randomized study involving patients with primary aldosteronism(PA). All participants will be randomized into finerenone group (Intervention group) and spironolactone group (Control group) and to compare the antihypertensive effect in patients with PA.
Clinical Study
Summary
Study Name: Efficacy and Safety of Finerenone in Patients With Primary Aldosteronism: a Randomized, Controlled Trial
Status: Recruiting
Conditions: Primary aldosteronism
Interventions: Drug: finerenone
Locations: Chongqing, Chongqing, China
Study link: https://clinicaltrials.gov/study/NCT05924620
To search for other studies by topic, location, or status, go to our Clinical Studies page.
